Results 241 to 250 of about 3,625,809 (366)

Prioritizing Feasible and Impactful Actions to Enable Secure AI Development and Use in Biology

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT As artificial intelligence continues to enhance biological innovation, the potential for misuse must be addressed to fully unlock the potential societal benefits. While significant work has been done to evaluate general‐purpose AI and specialized biological design tools (BDTs) for biothreat creation risks, actionable steps to mitigate the risk
Josh Dettman   +4 more
wiley   +1 more source

High-Throughput Screening of FDA-Approved Drug Library Reveals Ixazomib Is a Broad-Spectrum Antiviral Agent against Arboviruses. [PDF]

open access: yesViruses, 2022
Ding C   +13 more
europepmc   +1 more source

In vitro antiviral effect of sulfated pectin from Mangifera indica against the infection of the viral agent of childhood bronchiolitis (Respiratory Syncytial Virus - RSV)

open access: green
Mário Gabriel Lopes Barboza   +10 more
openalex   +2 more sources

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection [PDF]

open access: gold, 2017
Chen‐Hua Liu   +7 more
openalex   +1 more source

Advancing design strategies in smart stimulus‐responsive liposomes for drug release and nanomedicine

open access: yesBMEMat, EarlyView.
Schematic illustration of stimulus‐responsive liposomes designed for controlled drug release and nanomedicine. The innermost circle represents different liposomal structures, including unilamellar, multilamellar, and multivesicular liposomes. The middle layer illustrates the responsive phospholipid components.
Yuchen Guo   +9 more
wiley   +1 more source

SnO<sub>2</sub>NPs as a Nontoxic Antiviral Agent for Designing Protective Masks against Human Coronavirus Infection. [PDF]

open access: yesACS Appl Bio Mater
Baranowska-Korczyc A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy